Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Extracellular vesicles from stem cells rescue cellular phenotypes and behavioral deficits in SHANK3-associated ASD neuronal and mouse models.

Cell death & disease·2026

Same author

Novel approach to a severe craniomaxillofacial trauma in a military working dog using a customized 3D-printed mold for printed polymethylmethacrylate (PMMA) plate-a case report.

Frontiers in veterinary science·2025

Same author

A pilot study to assess the safety and feasibility of a wearable communication device in mechanically ventilated critically ill patients.

Journal of critical care·2025

Same author

Re: Response to Commentary.

Neurocritical care·2025

Same author

Intravenous Milrinone: Are We There yet?

Neurocritical care·2025

Same author

Earlier onset of cerebral vasospasm in ruptured infectious intracranial aneurysms.

Neurosurgical review·2025

Search research articles

Related Experiment Video

Updated: Jun 4, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

Differentiated mesenchymal stem cells for sciatic nerve injury.

Michal Dadon-Nachum¹, Ofer Sadan, Itay Srugo

¹Laboratory of Neurosciences, Felsenstein Medical Research Center, Beilinson Campus and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.

Stem Cell Reviews and Reports

|February 18, 2011

Summary

Transplanted astrocyte-like cells secreting neurotrophic factors (NTFs) significantly preserved motor function and protected neurons in rats with sciatic nerve injury. This autologous cell therapy shows promise for treating nerve damage and neurological disorders.

More Related Videos

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve

Published on: September 26, 2018

Related Experiment Videos

Last Updated: Jun 4, 2026

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Development of Combinatorial Therapeutics for Spinal Cord Injury using Stem Cell Delivery

Published on: June 7, 2024

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Neural Stem Cell Transplantation in Experimental Contusive Model of Spinal Cord Injury

Published on: December 17, 2014

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve

Nerve Stimulator-guided Injection of Autologous Stem Cells Near the Equine Left Recurrent Laryngeal Nerve

Published on: September 26, 2018

Area of Science:

Neuroscience
Regenerative Medicine
Cell Therapy

Background:

Sciatic nerve injury frequently leads to neurological deficits.
Neurotrophic factors (NTFs) are crucial for neuron survival and protection.
Previous research indicated NTFs protect damaged motor neurons.

Purpose of the Study:

To investigate the efficacy of astrocyte-like cells engineered to produce NTFs (NTF(+) cells) in a rat sciatic nerve injury model.
To evaluate the neuroprotective and functional recovery effects of NTF(+) cells on motor neurons.

Main Methods:

Bone marrow-derived mesenchymal stem cells were converted into NTF-secreting astrocyte-like cells (NTF(+) cells).
Rats underwent sciatic nerve crush injury and were transplanted with NTF(+) cells, mesenchymal stem cells (MSCs), or PBS into the lesion site.
Motor function, neuromuscular junction integrity, and myelinated motor axons were assessed.

Main Results:

Rats treated with NTF(+) cells exhibited markedly preserved motor function.
NTF(+) cell transplantation significantly inhibited neuromuscular junction degeneration.
Preservation of myelinated motor axons was observed in the NTF(+) cell treatment group.

Conclusions:

NTF(+) cells demonstrate significant therapeutic potential for sciatic nerve injury.
This autologous cell-based approach may alleviate signs of nerve damage and other neurological disorders.
The study highlights the promise of engineered NTF-producing cells for neural repair.